tumor immunology

Open Access
Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer
KOHEI MIYATA and FUSANORI YOTSUMOTO

Anticancer Research May 2026, 46 (5) 2851-2861; DOI: https://doi.org/10.21873/anticanres.18164
Open Access
Tumor Immunology Visualized in Realtime in In-vivo-like 3-D Gelfoam^® Histoculture by Color-coded Imaging
KOHEI MIZUTA, JOSE REYNOSO, YOHEI ASANO, BYUNG MO KANG, JIN SOO KIM, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research June 2025, 45 (6) 2279-2283; DOI: https://doi.org/10.21873/anticanres.17602
You have access
Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer
WATARU GOTO, SHINICHIRO KASHIWAGI, KOJI TAKADA, YUKA ASANO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research February 2022, 42 (2) 939-946; DOI: https://doi.org/10.21873/anticanres.15553
You have access
Long-term Follow-up After Interstitial Laser Thermotherapy of Breast Cancer
KRISTÍN-HULD HARALDSDÓTTIR, CHRISTIAN INGVAR, UNNE STENRAM and KARL-GÖRAN TRANBERG

Anticancer Research November 2015, 35 (11) 6147-6152;
You have access
Tumor Progression Is Associated with Increasing CD11b⁺ Cells and CCL2 in Lewis Rat Sarcoma
RAJBARDHAN MISHRA, JANA KOVALSKA, JOZEF JANDA, LUCA VANNUCCI, RADKO RAJMON and VRATISLAV HORAK

Anticancer Research February 2015, 35 (2) 703-711;

Main menu

User menu

Search

tumor immunology